Skip to main content
. 2022 Jan 30;11(3):485. doi: 10.3390/cells11030485

Figure 6.

Figure 6

Evaluation of bioluminescence and fluorescence signal in the “stroke + MSC” (G3) and “stroke + MSC + exercise” (G5) groups, in the following conditions: 4 h and 1, 3, 5, 7, 14, and 21 days after the administration of MSC labeled with MNP. (A) BLI and NIRF signal representations in the “stroke + MSC” (G3) and “stroke + MSC + exercise” (G5) groups over the time with detectable signal for both techniques (until 7 day); (B) The graphic of the BLI signal intensity of groups analyzed over time; and (C) The graphic of the NIRF signal intensity of groups analyzed over time.